Acción CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Charles River Laboratories International, Inc.

Acciones

CRL

US1598641074

Mercado cerrado - Nyse
Otros sitios de cotización
 22:00:02 26/04/2024 		Varia. Cinco días. Varia. 1 de enero.
229 USD +0,54 % Gráfico intradía de Charles River Laboratories International, Inc. +0,99 % -3,12 %
25/04 FibroBiologics, Inc. planea colaborar con Charles River Laboratories para fabricar esferoides basados en fibroblastos CI
24/04 Charles River Laboratories presenta un suplemento a la declaración de representación definitiva ante la Securities and Exchange Commission CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
FibroBiologics, Inc. Plans to Collaborate with Charles River Laboratories to Manufacture Fibroblast-Based Spheroids
Charles River Laboratories International : Proxy Supplement Filed April 24, 2024
Charles River Laboratories Files Supplement to Definitive Proxy Statement with the Securities and Exchange Commission
Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
Charles River Laboratories International : 2023 Corporate Citizenship Report
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
Charles River Laboratories International, Inc. and Deciphex Limited Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
Charles River Laboratories, Axovia Therapeutics Collaborate on Developing Rare Disease Gene Therapies
Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
Charles River Laboratories International, Inc. Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
Charles River Laboratories Signs Plasmid DNA Manufacturing Deal With Ship of Theseus
Charles River to Perform Plasmid Production for Ship of Theseus
Charles River to Perform Plasmid Production for Ship of Theseus
Charles River Laboratories International, Inc. and Ship of Theseus Announces Good Manufacturing Practice Plasmid DNA Contract Development and Manufacturing Organization Agreement
Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024
Charles River Laboratories International, Inc Receives a Shareholder Proposal from People for the Ethical Treatment of Animals
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción CRL
  4. Noticias Charles River Laboratories International, Inc.
  5. Otros idiomas